SYSTEMETRIC
LIVE

Serial Number

79149152

Owner

AsedaSciences AG

Attorney

Jeffrey A. Smith

Filing Date

Apr 29, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SYSTEMETRIC Trademark

Serial Number: 79149152 • Registration: 4774665

SYSTEMETRIC is a trademark filed by AsedaSciences AG on April 29, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AsedaSciences AG (6 trademarks)

Untere Paulistrasse 6a
Schindellegi CH-8834 , CH

Entity Type: 99

Trademark Details

Filing Date

April 29, 2014

Registration Date

July 21, 2015

Published for Opposition

May 5, 2015

Goods & Services

[ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]

Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services [ and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] pharmaceutical research and development; Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]

[ Scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; Laboratory apparatus and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 19, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
May 19, 2026 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2026 APRE
TEAS SECTION 71 RECEIVED
Jan 20, 2026 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jul 21, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 4, 2024 RNWL
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 7, 2023 LIMN
PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 28, 2023 INNP
LIMITATION OF GOODS RECEIVED FROM IB
Mar 27, 2023 LIMG
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 22, 2023 INPS
INVALIDATION PROCESSED
Feb 22, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 1, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 1, 2022 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
May 1, 2022 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2022 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 16, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Jul 21, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 2, 2015 FICS
FINAL DISPOSITION PROCESSED
Dec 2, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2015 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 15, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 27, 2015 PREV
ASSIGNED TO LIE
Mar 27, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 23, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 23, 2014 REAP
REFUSAL PROCESSED BY IB
Sep 11, 2014 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2014 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2014 RFCR
NON-FINAL ACTION WRITTEN
Aug 25, 2014 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 25, 2014 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 22, 2014 RFCR
NON-FINAL ACTION WRITTEN
Aug 21, 2014 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 2, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 19, 2014 REPR